tiprankstipranks
Trending News
More News >
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
US Market

Rapport Therapeutics, Inc. (RAPP) Income Statement

Compare
115 Followers

Rapport Therapeutics, Inc. Income Statement

Last quarter (Q3 2025), Rapport Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Rapport Therapeutics, Inc.'s net income was $-26.93M. See Rapport Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ -839.00K$ -112.00K$ -15.00K
Operating Expenses
$ 82.22M$ 36.07M$ 10.35M
Depreciation and Amortization
$ 839.00K$ 112.00K$ 15.00K
EBITDA
$ -77.47M$ -34.66M$ -10.35M
Operating Income
$ -83.06M$ -36.18M$ -10.37M
Other Income/Expenses
$ 4.75M$ 1.40M$ -285.00K
Pretax Income
$ -78.31M$ -34.78M$ -10.65M
Net Income
$ -78.31M$ -34.79M$ -10.65M
Per Share Metrics
Basic EPS
$ -0.38$ -0.19$ -0.05
Diluted EPS
$ -0.38$ -0.19$ -0.05
Weighted Average Shares Outstanding
207.38M 180.79M 201.17M
Weighted Average Shares Outstanding (Diluted)
207.38M 180.79M 201.17M
Currency in USD

Rapport Therapeutics, Inc. Earnings and Revenue History